Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Tumour lysis syndrome: new therapeutic strategies and classification.

Cairo MS, Bishop M.

Br J Haematol. 2004 Oct;127(1):3-11. Review.

PMID:
15384972
2.

An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.

Mughal TI, Ejaz AA, Foringer JR, Coiffier B.

Cancer Treat Rev. 2010 Apr;36(2):164-76. doi: 10.1016/j.ctrv.2009.11.001. Epub 2009 Dec 23. Review. Erratum in: Cancer Treat Rev. 2010 Aug;36(5):442.

PMID:
20031331
3.

Tumor lysis syndrome.

Jeha S.

Semin Hematol. 2001 Oct;38(4 Suppl 10):4-8. Review.

PMID:
11694945
4.

Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.

Cairo MS, Coiffier B, Reiter A, Younes A; TLS Expert Panel.

Br J Haematol. 2010 May;149(4):578-86. doi: 10.1111/j.1365-2141.2010.08143.x. Epub 2010 Mar 16. Review.

PMID:
20331465
5.

Rasburicase: a new approach for preventing and/or treating tumor lysis syndrome.

Bessmertny O, Robitaille LM, Cairo MS.

Curr Pharm Des. 2005;11(32):4177-85. Review.

PMID:
16375739
6.

Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.

Coiffier B, Altman A, Pui CH, Younes A, Cairo MS.

J Clin Oncol. 2008 Jun 1;26(16):2767-78. doi: 10.1200/JCO.2007.15.0177. Review. Erratum in: J Clin Oncol. 2010 Feb 1;28(4):708.

PMID:
18509186
7.

The clinical management of tumour lysis syndrome in haematological malignancies.

Will A, Tholouli E.

Br J Haematol. 2011 Jul;154(1):3-13. doi: 10.1111/j.1365-2141.2011.08697.x. Epub 2011 May 9. Review.

PMID:
21554259
8.

Management of pediatric tumor lysis syndrome.

Tazi I, Nafl H, Elhoudzi J, Mahmal L, Harif M.

Arab J Nephrol Transplant. 2011 Sep;4(3):147-54. Review.

PMID:
22026339
9.

Tumor lysis syndrome in elderly.

Pumo V, Sciacca D, Malaguarnera M.

Crit Rev Oncol Hematol. 2007 Oct;64(1):31-42. Epub 2007 Jul 19. Review.

PMID:
17658268
10.

[Tumor lysis syndrome].

Jeddi R, Ben Abdennebi Y, Allani B, Belakhal R, Aissaoui L, Ben Abid H, Ali ZB, Meddeb B.

Tunis Med. 2007 Feb;85(2):174-6. Review. French.

PMID:
17665670
11.

Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.

Baeksgaard L, Sørensen JB.

Cancer Chemother Pharmacol. 2003 Mar;51(3):187-92. Epub 2003 Feb 28.

PMID:
12655435
12.

Tumor lysis syndrome: a systematic review of case series and case reports.

Firwana BM, Hasan R, Hasan N, Alahdab F, Alnahhas I, Hasan S, Varon J.

Postgrad Med. 2012 Mar;124(2):92-101. doi: 10.3810/pgm.2012.03.2540. Review.

PMID:
22437219
13.

[Tumor lysis syndrome].

Hagino T.

Gan To Kagaku Ryoho. 2010 Jun;37(6):984-8. Japanese.

PMID:
20567098
14.

Treatment of tumor lysis syndrome with the highest known uric acid level.

Ozkan G, Ulusoy S, Sönmez M, Kaynar K, Karagülle M.

Ren Fail. 2010;32(7):895-8. doi: 10.3109/0886022X.2010.494795.

PMID:
20662707
15.

Rasburicase for the management of tumor lysis syndrome in neonates.

McNutt DM, Holdsworth MT, Wong C, Hanrahan JD, Winter SS.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1445-50.

PMID:
16868218
16.

Tumor lysis syndrome.

Tiu RV, Mountantonakis SE, Dunbar AJ, Schreiber MJ Jr.

Semin Thromb Hemost. 2007 Jun;33(4):397-407. Review.

PMID:
17525897
17.
18.

Clarifying the role of rasburicase in tumor lysis syndrome.

Sood AR, Burry LD, Cheng DK.

Pharmacotherapy. 2007 Jan;27(1):111-21. Review.

PMID:
17192165
19.

The management of tumor lysis syndrome.

Rampello E, Fricia T, Malaguarnera M.

Nat Clin Pract Oncol. 2006 Aug;3(8):438-47. Review.

PMID:
16894389
20.

Tumour lysis syndrome: implications for cancer therapy.

Mika D, Ahmad S, Guruvayoorappan C.

Asian Pac J Cancer Prev. 2012;13(8):3555-60. Review.

Supplemental Content

Support Center